Evogene | EVGN - Ebitda

Aktienkurs
244.80
Täglich Wechseln
2.10 0.87%
Monatlich
-13.28%
Jährlich
-38.74%
Q2 Prognose
237.60




Ebitda Veränderung Datum
CVR Partners USD 70.62M 3.41M 2025-09
Evogene USD -4.95M 2.51M 2025-12
Globe Specialty Metals USD 14.59M 3.68M 2025-12
Hawkins USD 35.97M 11.96M 2025-12
Innospec USD 55.7M 12.4M 2025-12
Intrepid Potash USD 6.85M 119K 2024-09
Koppers USD 53.2M 17.7M 2025-12
Kronos Worldwide USD -57.9M 58.5M 2025-12
LSB Industries USD 54.08M 13.98M 2025-12
Materion USD 57M 1.5M 2025-12
Minerals Technologies USD 87.3M 13M 2025-12
Rayonier Advanced Materials USD 46M 2.5M 2025-12
Sensient Technologies USD 86.04M 23.01M 2026-03
Stepan USD 33.8M 22.4M 2025-12
Tronox USD 57M 17M 2025-12
Valhi USD 24.4M 21.4M 2025-09
WD-40 USD 28.66M 3.3M 2025-12